Are you Dr. Femia?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
222 E 41st St
Fl 16
New York, NY 10017Phone+1 212-263-5889Fax+1 212-263-7680
Summary
- Dr. Alisa Femia, MD is a board certified dermatologist in New York, New York. She is currently licensed to practice medicine in New York and Massachusetts. She is affiliated with NYU Langone Hospitals and NYC Health + Hospitals / Bellevue.
Education & Training
- Stony Brook Medicine/University HospitalResidency, Dermatology, 2009 - 2012
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2008 - 2009
- Stony Brook University Health Sciences Center School of MedicineClass of 2008
Certifications & Licensure
- NY State Medical License 2013 - 2026
- MA State Medical License 2012 - 2015
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 1 citationsAnifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort study.Katharina S Shaw, Kimberly B Hashemi, Rochelle L Castillo, Elizabeth Rainone, Allen W Ho
Journal of the American Academy of Dermatology. 2024-12-01 - Non-steroidal Immune Modulating Therapies and Reduced Risk of Adverse Cardiovascular Events in Dermatomyositis and Polymyositis: A Cohort Study in the All of Us Resear...Jill T Shah, Keya T Shah, Soutrik Mandal, Michael S Garshick, Alisa N Femia
Journal of the American Academy of Dermatology. 2024-11-13 - Clinical Application of New Risk-Based Cancer Screening in Patients With Dermatomyositis.Andrea D Maderal, Alisa Femia
JAMA Dermatology. 2024-11-01
Press Mentions
- Dermatomyositis Cancer Screening Guidelines Get Real-World ValidationOctober 3rd, 2024
- NYU Langone Health in the News—Monday, May 8, 2023May 8th, 2023
- More Data Needed to Better Understand COVID-19 Skin ManifestationsJuly 31st, 2020